References
- Baweja, R., Mayes, S. D., Hameed, U., & Waxmonsky, J. G. (2016). Disruptive mood dysregulation disorder: Current insights. Neuropsychiatric Disease and Treatment, 24(12), 2115–2124. doi:10.2147/NDT.S100312.
- Dean, A. J., McDermott, B. M., & Marshall, R. T. (2006). Psychotropic medication utilization in a child and adolescent mental health service. Journal of the American Academy of Child and Adolescent Psychiatry, 16(3), 273–285. doi:10.1089/cap.2006.16.273.
- Doey, T., Handelman, K., Seabrook, J. A., & Steele, M. (2007). Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years. Canadian Journal of Psychiatry, 52(6), 363–368. doi:10.1177/070674370705200605.
- Greenhill, L., Shockey, E., Davies, M., Fisher, P., Fried, J., Capasso, L., … Scahill, L. (2003). Review of safety assessment methods used in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 42(6), 627–633. doi:10.1097/01.CHI.0000046841.56865.37.
- Harrison-Woolrych, M., Garcia-Quiroga, J., Ashton, J., & Herbison, P. (2007). Safety and usage of atypical antipsychotic medicines in children: A nationwide prospective cohort study. Drug Safety, 30(7), 569–579.
- Karanges, E. A., Stephenson, C. P., & McGregor, I. S. (2014). Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009–2012: Focus on children, adolescents and prescriber specialty. Australian & New Zealand Journal of Psychiatry, 48(10), 917–931. doi:10.1177/0004867414538675.
- Loy, J. H., Merry, S. N., Hetrick, S. E., & Stasiak, K. (2017). Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database of Systematic Reviews, 8, CD008559. doi:10.1002/14651858.CD008559.pub3.
- NHS England. (2014). NHS Standard Contract for Tier 4 Child and Adolescent Mental Health Services (CAMHS), Service specification C07/S/b.
- National Institute for Clinical Excellence (NICE). (2013, March). Antisocial behaviour and conduct disorders in children and young people: Recognition and management, Clinical Guideline (CG158).
- Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry, 49(1), 13–23.
- Rani, F., Murray, M. L., Byrne, P. J., & Wong, I. C. K. (2008). Epidemiologic feature of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics, 121(5), 1002–1009. doi:10.1542/peds.2007-2008.